Table 1.
SLE risk loci identified through GWAS in various ethnic groups
Study | Strong evidence (P<5×10–8 Gene (OR))
|
Good evidence (P<10–5) Gene (OR)
|
||
---|---|---|---|---|
Established* | Novel‡ | Established* | Novel‡ | |
European
| ||||
Hom et al.4 |
HLA-DR3 (ND) IRF53 (ND) STAT4 (ND) |
C8orf13-BLK (1.4) ITGAM-ITGAX (1.3) |
NA | NA |
| ||||
Harley et al.5 | HLA region (1.4–2.3) IRF5 (1.3–1.6) STAT4 (1.5) |
ITGAM (1.3–1.7) PHRF1 (1.3) PXK (1.3) XKR6§ (1.2–1.3) BLK (1.2) LYN (1.3) |
PTPN22 (1.5) FCGR2A (1.4) |
ATG5 (1.2) UBE2L3 (1.2) SCUBE1 (1.3) |
| ||||
Kozyrev et al.6 | NA | BANK1 (1.4) | NA | NA |
| ||||
Graham et al.7 | HLA region (ND) IRF53 (ND) STAT4 (1.5) |
BLK (1.3) TNFAIP3 (2.3) |
NA | ITGAM (ND) |
| ||||
Gateva et al.8|| |
HLA-DRB1 (2.0) IRF5 (1.9) STAT4 (1.6) PTPN22 (1.4) TNFSF4 (1.2) IL10 (1.2) |
ITGAM (1.4) BLK (1.4) TNFAIP3 (1.7) PHRF1 (1.2) TNIP1 (1.3) PRDM1-ATG5 (1.2) JAZF1§ (1.2) UHRF1BP1§ (1.2) |
IRAK1-MECP2(1.1) |
UBE2L3 (1.2) ATG5 (1.2) PXK (1.2) IKZF1 (1.2) SLC15A4 (1.1) |
| ||||
Asian
| ||||
Han et al.9 | HLA region (1.9) IRF5 (1.4) STAT4 (1.5) TNFSF4(1.4–1.5) |
BLK (1.3–1.4) PRDM1-ATG5 (1.3) TNFAIP3 (1.7) HIC-UBE2L3 (1.3) IKZF1§ (1.4) RASGRP3§ (1.4) SLC15A4§ (1.3) TNIP1 (1.3) ETS1 (1.4) LRRC18-WDFY4 (1.2) |
NA | NA |
| ||||
Yang et al.10 | HLA region(1.8–2.0) STAT4 (1.7) |
ETS1 (1.3) WDFY4 (1.3) |
IRF5 (1.5) |
TNFAIP3 (1.9) BLK (1.6) |
Loci identified through candidate gene studies and GWAS.
Loci identified through GWAS only.
Have not been replicated independently at the time of writing.
Used a similar cohort to the Hom et al.4 study.
Abbreviations: GWAS, genome-wide association studies; NA, not applicable; ND, not determined; OR, odds ratio; SLE, systemic lupus erythematosus.